2023

1. Adjuvant dabrafenib and trametinib for patients with resected BRAF -mutated melanoma: DESCRIBE-AD real-world retrospective observational study

   Melanoma research, Vol. 33, Núm. 5, pp. 388-397

2. Real-world safety and effectiveness of maintenance niraparib for platinum-sensitive recurrent ovarian cancer: A GEICO retrospective observational study within the Spanish expanded-access programme

   European Journal of Cancer, Vol. 182, pp. 3-14